Work

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate

Year: 2017
Type: article
Abstract: Mutations in the glucocerebrosidase 1 (GBA1) gene are related to both Parkinson disease (PD) and Gaucher disease (GD). In both cases, the condition is associated with deficiency of glucocerebrosidase (GCase), the enzyme encoded by GBA1. Ambroxol is a small molecule chaperone that has been shown in mice to cross the blood-brain barrier, increase GCase activity and reduce alpha-synuclein protein levels. In this study, we analyze the effect of ambroxol treatment on GCase activity in healthy nonhuman primates. We show that daily administration of ambroxol results in increased brain GCase activity. Our work further indicates that ambroxol should be investigated as a novel therapy for both PD and neuronopathic GD in humans.
Source: Synapse
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $1,850
OpenAlex ID: W2592033002
FWCI: 10.78
Cites: 12
Cited by: 130
Related to: 9